Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0404 per EA under NDC 00172344480. Its NADAC has been published 49 times since Jul 23, 2025.
Strength
12.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00172344480
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA083177On Market Since
6/3/2025
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 49 times since Jul 23, 2025, and over the history we have for it it has declined 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0404 per EA |
|---|---|
| All-time high | $0.0436 (Aug 13, 2025) |
| All-time low | $0.0403 (Dec 17, 2025) |
| 52-week high | $0.0436 |
| 52-week low | $0.0403 |
| Median price | $0.0410 |
| Average price | $0.0414 |
| Largest weekly change | -3.8% (Oct 22, 2025) |
| Weeks tracked | 49 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0404 per EA (NDC 00172344480), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 7.4%. It has been tracked across 49 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Jul 23, 2025, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0403 (Dec 17, 2025) to a high of $0.0436 (Aug 13, 2025), with a median of $0.0410 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0284 per EA — about 30% below HYDROCHLOROTHIAZIDE 12.5 MG TB.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 00172344480) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification